DOI: 10.1093/ofid/ofag227 ISSN: 2328-8957
Is There Value in Performing Yearly Screening for Latent Tuberculosis Infection by Interferon-Gamma Release Assay Among Patients Living With HIV in Non-Endemic Settings?
Carlo Foppiano Palacios, Amit Achhra, Lydia Barakat, Michael Virata, Ritche Hao, John Baxter, Maricar MalinisAbstract
We evaluated the effectiveness of annual LTBI screening via IGRA in people with HIV in non-endemic settings over 5 years. Out of 1898 patients with at least 2 IGRAs, only 12 developed new LTBI, highlighting the low yield of universal screening. Findings support targeted screening per current guidelines.